Abstract
Purpose of Review
This review summarizes recent innovations in the treatment of patients with short bowel syndrome.
Recent Findings
The use of surgical procedures, growth factor stimulation, and bioengineering approaches to increase absorptive surface area of the intestine is examined. While the morphology of the intestine is clearly altered by these interventions, it is less clear that the overall function of the intestine is improved.
Summary
Continued innovations will likely bring about new therapeutic options for patients with short bowel syndrome. Careful evaluations of the impact of these interventions await controlled clinical trials.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Wales PW, De Silva N, Kim J, Lecce L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg. 2004;39:690–5.
Spencer AU, Kovacevich D, McKinney-Barnett M, Hair D, Canham J, Maksym C, et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr. 2008;88(6):1552–9.
Fallon EM, Mitchell PD, Nehra D, Potemkin AK, O’Loughlin AA, Gura KM, et al. Neonates with short bowel syndrome. JAMA Surg. 2014;149(7):663.
King B, Carlson G, Khalil BA, Morabito A. Intestinal bowel lengthening in children with short bowel syndrome: systematic review of the Bianchi and STEP procedures. World J Surg. 2013;37:694–704.
• Oh PS, Fingeret AL, Shah MY, Ventura KA, Brodlie S, Ovchinsky N, et al. Improved tolerance for enteral nutrition after serial transverse enteroplasty (STEP) in infants and children with short bowel syndrome—a seven-year single-center experience. J Pediatr Surg Elsevier Inc. 2014;49(11):1589–92. A single center study examining enteral autonomy and improved enteral tolerance with STEP
•• Fernandes MA, Usatin D, Allen IE, Rhee S, Vu L. Improved enteral tolerance following step procedure: systematic literature review and meta-analysis. Pediatr Surg Int Springer Berlin Heidelberg. 2016;32(10):921–6. Recent meta-analysis of STEP compiling seven different studies
Jones BA, Hull MA, Potanos KM, Zurakowski D, Fitzgibbons SC, Ching YA, et al. Report of 111 consecutive patients enrolled in the international serial transverse enteroplasty (STEP) data registry: a retrospective observational study. J Am Coll Surg American College of Surgeons. 2013;216(3):438–46.
• Garnett GM, Kang KH, Jaksic T, Woo RK, Puapong DP, Kim HB, et al. First STEPs: serial transverse enteroplasty as a primary procedure in neonates with congenital short bowel. J Pediatr Surg. Elsevier Inc. 2014;49(1):104–8. Demonstrates role for primary treatment with STEP in neonates
Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF, Hartmann B, Holst JJ, et al. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1 + GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept Elsevier BV. 2013;184:30–9.
Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Drugs. 2013;73(9):935–47.
McKeage K. Teduglutide: a guide to its use in short bowel syndrome. Clin Drug Investig. 2015;35(5):335–40.
Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O’Keefe SJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60(7):902–14.
Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O’Keefe SJD, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143(6):1473–1481.e3.
• Schwartz LK, O’Keefe SJD, Fujioka K, Gabe SM, Lamprecht G, Pape U-F, et al. Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome. Clin Transl Gastroenterol. 2016;7:e142. Demonstrates sustained wean from parentral nutrition in adults taking teduglutide
• Fujioka K, Jeejeebhoy K, Pape U-F, Li B, Youssef NN, Schneider SM. Patients with short bowel on narcotics during 2 randomized trials have abdominal complaints independent of teduglutide. JPEN J Parenter Enteral Nutr. 2016. In adults, adverse abdominal complaints relate more to underlying intestinal dysfunction than to teduglutide
•• Sullins VF, Scott A, Wagner JP, Steinberger D, Lee SL, Wu BM, et al. Intestinal lengthening in an innovative rodent surgical model. J Pediatr Surg. 2014;49(12):1791–4. Development of a novel biodegradable spring for use in distraction enterogenesis, moving away from devices that would require both surgical placement and removal
Grant CN, Salvador GM, Sala FG, Hill JR, Levin DE, Speer AL, et al. Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function. Am J Physiol Gastrointest Liver Physiol. 2015; doi:10.1152/ajpgi.00111.2014.
Koga H, Sun X, Yang H, Nose K, Somara S, Bitar KN, et al. Distraction-induced intestinal enterogenesis: preservation of intestinal function and lengthening after reimplantation into normal jejunum. Ann Surg. 2012;255(2):302–10.
Stark R, Panduranga M, Carman G, Dunn JCY. Development of an endoluminal intestinal lengthening capsule. J Pediatr Surg. Elsevier Inc. 2012;47(1):136–41.
Okawada M, Mustafa Maria H, Teitelbaum DH. Distraction induced enterogenesis: a unique mouse model using polyethylene glycol. J Surg Res. 2011;170(1):41–7.
Sullins VF, Wagner JP, Suwarnasarn AT, Lee SL, Wu BM, Dunn JCY. A novel biodegradable device for intestinal lengthening. J Pediatr Surg Elsevier Inc. 2014;49(1):109–13. discussion 113
Scott A, Sullins VF, Steinberger D, Rouch JD, Wagner JP, Chiang E, et al. Repeated mechanical lengthening of intestinal segments in a novel model. J Pediatr Surg. 2015;50(6):954–7. doi:10.1016/j.jpedsurg.2015.03.020.
Fisher JG, Sparks EA, Khan FA, Dionigi B, Wu H, Brazzo J, et al. Extraluminal distraction enterogenesis using shape-memory polymer. J Pediatr Surg. 2015;50:938–42.
Dionigi B, Brazzo J, Connors JP, Ahmed A, Fisher JG, Zurakowski D, et al. Extraluminal helicoidal stretch (Helixtretch): a novel method of intestinal lengthening. J Pediatr Surg. 2014;49(12):1787–90.
Sueyoshi R, Woods Ignatoski KM, Okawada M, Teitelbaum DH. Distraction-induced intestinal growth: the role of mechanotransduction mechanisms in a mouse model of short bowel syndrome. Tissue Eng Part A. 2013;20:131106060201007.
Sueyoshi R, Ralls MW, Teitelbaum DH. Glucagon-like peptide 2 increases efficacy of distraction enterogenesis. J Surg Res. 2013;184(1):365–73.
Rouch JD, Scott A, Jabaji ZB, Chiang E, Wu BM, Lee SL, et al. Basic fibroblast growth factor eluting microspheres enhance distraction enterogenesis. J Pediatr Surg. 2016;51(6):960–5.
Demehri FR, Wong PM, Freeman JJ, Fukatsu Y, Teitelbaum DH. A novel double-balloon catheter device for fully endoluminal intestinal lengthening. Pediatr Surg Int. 2014;30(12):1223–9.
Demehri FR, Freeman JJ, Fukatsu Y, Luntz J, Teitelbaum DH. Development of an endoluminal intestinal lengthening device using a geometric intestinal attachment approach. Surgery (United States). 2015;158:802–11.
•• Demehri FR, Utter B, Freeman JJ, Fukatsu Y, Luntz J, Brei D, et al. Development of an endoluminal intestinal attachment for a clinically applicable distraction enterogenesis device. J Pediatr Surg. 2016;51:101–6. One of the first large animal models demonstrating translatability of distraction enterogenesis
• Huynh N, Rouch JD, Scott A, Chiang E, Wu BM, Shekherdimian S, et al. Spring-mediated distraction enterogenesis in-continuity. J Pediatr Surg. 2016;51(12):1983–7. Study showing the feasibility of an in-continuity lengthening device in a translatable, large animal model
• Rouch JD, Huynh N, Scott A, Chiang E, Wu BM, Shekherdimian S, et al. Scalability of an endoluminal spring for distraction enterogenesis. J Pediatr Surg. 2016;51(12):1988–92. Study providing a scalable factor that could be used for eventual translatability of spring force in distraction enterogenesis
Walton KD, Freddo AM, Wang S, Gumucio DL. Generation of intestinal surface: an absorbing tale. Development. 2016;143(13):2261–72.
Cromeens BP, Liu Y, Stathopoulos J, Wang Y, Johnson J, Besner GE. Production of tissue-engineered intestine from expanded enteroids. J Surg Res Elsevier Inc. 2016;204(1):164–75.
•• Watson CL, Mahe MM, Múnera J, Howell JC, Sundaram N, Poling HM, et al. An in vivo model of human small intestine using pluripotent stem cells. Nat Med. 2014;20(11):1310–4. Landmark study demonstrating that tissue-engineered intestine from induced pluripotent stem cells has morphologically similarities and is functionally competent
Liu Y, Nelson T, Cromeens B, Rager T, Lannutti J, Johnson J, et al. HB-EGF embedded in PGA/PLLA scaffolds via subcritical CO2 augments the production of tissue engineered intestine. Biomaterials Elsevier Ltd. 2016;103:150–9.
Zachos NC, Kovbasnjuk O, Foulke-Abel J, In J, Blutt SE, De Jonge HR, et al. Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J Biol Chem. 2016;291(8):3759–66.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Joshua D. Rouch and James C.Y. Dunn declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Surgical
Rights and permissions
About this article
Cite this article
Rouch, J.D., Dunn, J.C.Y. New Insights and Interventions for Short Bowel Syndrome. Curr Pediatr Rep 5, 1–5 (2017). https://doi.org/10.1007/s40124-017-0119-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40124-017-0119-6